title: Molecular toxicology endpoints in rodent inhalation studies.
abstract: Although histopathology will continue to be essential for assessing the results of rodent inhalation studies, molecular toxicology endpoints are of increasing importance, as these techniques often complement and extend histopathological examinations. One of the primary uses of molecular toxicology is determining the delivered dose of the inhaled material to macromolecules in target tissues. During inhalation studies this is most often done by measuring DNA adducts in the respiratory tract. DNA adducts may be measured specifically (e.g. using monoclonal antibodies or mass spectrometry) or non-specifically (e.g. by using the 32P-post-labeling assay). Another major use of molecular toxicology techniques is the assessment of cellular and molecular changes in target tissues which may precede or be more sensitive than histopathologic alterations. For example, rates of cellular DNA synthesis occurring in target tissues may be quantified at any time during the study by administering the animals either radiolabelled thymidine or the non-radiolabelled thymidine analog bromodeoxyuridine (BrdU). Pulmonary changes may be assessed in bronchoalveolar lavage fluid using either cellular (e.g. macrophage number, granulocyte number) or biochemical (e.g. alkaline phosphatase, lactate dehydrogenase) techniques. The potential of the inhaled material to produce genetic alterations may be evaluated by examining the chromosomes of pulmonary alveolar macrophages for cytogenetic changes. To illustrate the use of these endpoints, an experiment was conducted to determine the molecular toxicology of aged and diluted sidestream smoke (a surrogate for environmental tobacco smoke) in rodent inhalation studies. The endpoints measured were DNA adducts in target and non-target tissue, chromosome aberrations in pulmonary alveolar macrophages, and DNA synthesis in the epithelial lining of the nasal turbinates.
authors.affiliation: Environmental and Molecular Toxicology Division Research and Development, R.J. Reynolds Tobacco Co., Winston-Salem, North Carolina, USA.
authors.forename: B G
authors.initials: BG
authors.lastname: Brown
authors.forename: B R
authors.initials: BR
authors.lastname: Bombick
authors.forename: S C
authors.initials: SC
authors.lastname: McKarns
authors.forename: C K
authors.initials: CK
authors.lastname: Lee
authors.forename: P H
authors.initials: PH
authors.lastname: Ayres
authors.forename: D J
authors.initials: DJ
authors.lastname: Doolittle
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002869:Chromosome Aberrations; D051381:Rats; D014028:Tobacco Smoke Pollution / Q000009:adverse effects*
chemical_list: D014028:Tobacco Smoke Pollution